178 related articles for article (PubMed ID: 36249025)
1. Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis.
Chedere A; Mishra M; Kulkarni O; Sriraman S; Chandra N
Front Oncol; 2022; 12():954512. PubMed ID: 36249025
[TBL] [Abstract][Full Text] [Related]
2. NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer.
Li XQ; Lei J; Mao LH; Wang QL; Xu F; Ran T; Zhou ZH; He S
Front Oncol; 2019; 9():736. PubMed ID: 31448236
[TBL] [Abstract][Full Text] [Related]
3. Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators.
Baldassarri C; Giorgioni G; Piergentili A; Quaglia W; Fontana S; Mammoli V; Minazzato G; Marangoni E; Gasparrini M; Sorci L; Raffaelli N; Cappellacci L; Petrelli R; Del Bello F
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259338
[TBL] [Abstract][Full Text] [Related]
4. Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery.
Ghanem MS; Caffa I; Del Rio A; Franco J; Parenti MD; Monacelli F; Cea M; Khalifa A; Nahimana A; Duchosal MA; Ravera S; Bertola N; Bruzzone S; Nencioni A; Piacente F
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890147
[TBL] [Abstract][Full Text] [Related]
5. NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma.
Peterse EFP; van den Akker BEWM; Niessen B; Oosting J; Suijker J; de Jong Y; Danen EHJ; Cleton-Jansen AM; Bovée JVMG
Mol Cancer Res; 2017 Dec; 15(12):1714-1721. PubMed ID: 28860121
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy.
Kim M; Kim H; Kang BG; Lee J; Kim T; Lee H; Jung J; Oh MJ; Seo S; Ryu MJ; Sung Y; Lee Y; Yeom J; Han G; Cha SS; Jung H; Kim HS
Theranostics; 2023; 13(14):5075-5098. PubMed ID: 37771778
[No Abstract] [Full Text] [Related]
7. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Piacente F; Caffa I; Ravera S; Sociali G; Passalacqua M; Vellone VG; Becherini P; Reverberi D; Monacelli F; Ballestrero A; Odetti P; Cagnetta A; Cea M; Nahimana A; Duchosal M; Bruzzone S; Nencioni A
Cancer Res; 2017 Jul; 77(14):3857-3869. PubMed ID: 28507103
[TBL] [Abstract][Full Text] [Related]
8. Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Xiao Y; Elkins K; Durieux JK; Lee L; Oeh J; Yang LX; Liang X; DelNagro C; Tremayne J; Kwong M; Liederer BM; Jackson PK; Belmont LD; Sampath D; O'Brien T
Neoplasia; 2013 Oct; 15(10):1151-60. PubMed ID: 24204194
[TBL] [Abstract][Full Text] [Related]
9. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.
Revollo JR; Grimm AA; Imai S
Curr Opin Gastroenterol; 2007 Mar; 23(2):164-70. PubMed ID: 17268245
[TBL] [Abstract][Full Text] [Related]
10. NAD metabolism and the SLC34 family: evidence for a liver-kidney axis regulating inorganic phosphate.
Tatsumi S; Katai K; Kaneko I; Segawa H; Miyamoto KI
Pflugers Arch; 2019 Jan; 471(1):109-122. PubMed ID: 30218374
[TBL] [Abstract][Full Text] [Related]
11. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D
Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854
[TBL] [Abstract][Full Text] [Related]
12. Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy.
Cole J; Guiot MC; Gravel M; Bernier C; Shore GC; Roulston A
Oncotarget; 2017 Sep; 8(44):77846-77859. PubMed ID: 29100430
[TBL] [Abstract][Full Text] [Related]
13. Subcellular Characterization of Nicotinamide Adenine Dinucleotide Biosynthesis in Metastatic Melanoma by Using Organelle-Specific Biosensors.
Gaudino F; Manfredonia I; Managò A; Audrito V; Raffaelli N; Vaisitti T; Deaglio S
Antioxid Redox Signal; 2019 Nov; 31(15):1150-1165. PubMed ID: 31456414
[No Abstract] [Full Text] [Related]
14. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
[TBL] [Abstract][Full Text] [Related]
15. NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease.
Colombo G; Caviglia GP; Ravera A; Tribocco E; Frara S; Rosso C; Travelli C; Genazzani AA; Ribaldone DG
Front Med (Lausanne); 2023; 10():1116862. PubMed ID: 36817780
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors.
Franco J; Piacente F; Walter M; Fratta S; Ghanem M; Benzi A; Caffa I; Kurkin AV; Altieri A; Herr P; Martínez-Bailén M; Robina I; Bruzzone S; Nencioni A; Del Rio A
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890155
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD
Guo J; Lam LT; Longenecker KL; Bui MH; Idler KB; Glaser KB; Wilsbacher JL; Tse C; Pappano WN; Huang TH
Biochem Biophys Res Commun; 2017 Sep; 491(3):681-686. PubMed ID: 28756225
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue NAD
Yamaguchi S; Franczyk MP; Chondronikola M; Qi N; Gunawardana SC; Stromsdorfer KL; Porter LC; Wozniak DF; Sasaki Y; Rensing N; Wong M; Piston DW; Klein S; Yoshino J
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23822-23828. PubMed ID: 31694884
[TBL] [Abstract][Full Text] [Related]
19. The role of NAD metabolism in neuronal differentiation.
Neves D; Goodfellow BJ; Vieira SI; Silva RM
Neurochem Int; 2022 Oct; 159():105402. PubMed ID: 35843422
[TBL] [Abstract][Full Text] [Related]
20. NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.
Audrito V; Messana VG; Deaglio S
Front Oncol; 2020; 10():358. PubMed ID: 32266141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
